tallimustine has been researched along with carzelesin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Beria, I; Caldarelli, M; Cozzi, P; Geroni, C; Marchini, S; Mongelli, N; Romagnoli, R | 1 |
| Bisiach, M; D'Incalci, M; Filippini, C; Tagliabue, G; Ubezio, P | 1 |
2 other study(ies) available for tallimustine and carzelesin
| Article | Year |
|---|---|
Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Distamycins; Drug Screening Assays, Antitumor; Female; Glutathione; Guanidines; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Structure-Activity Relationship; Transplantation, Heterologous | 2004 |
Hematopoietic toxicity and cell cycle perturbations induced by new DNA minor groove-alkylating agents.
Topics: Animals; Antineoplastic Agents, Alkylating; Benzofurans; Body Weight; Bone Marrow Cells; Cell Cycle; Cell Division; Distamycins; Duocarmycins; Flow Cytometry; Indoles; Leukocyte Count; Male; Melphalan; Mice; Mice, Inbred Strains; Neutropenia; Nitrogen Mustard Compounds; Survival Rate; Thrombocytopenia | 1997 |